Author:
Hayashi Saeko,Oishi Fumiko,Sato Kazuki,Fukuda Hiromi,Ando Shoko
Abstract
Abstract
Purpose
We investigated the experiences of Japanese men with sexual dysfunction associated with various prostate cancer treatments.
Methods
We included 38 Japanese men who underwent the following initial treatments for prostate cancer: radical prostatectomy (n = 10), external beam radiotherapy (n = 12), brachytherapy (n = 5), and androgen deprivation therapy (n = 11). Semi-structured interviews were conducted regarding sexual dysfunction associated with prostate cancer treatment. Data were analyzed using a content analysis method. To obtain a unique experience for each treatment, we confirmed and organized the treatment method from which the code that constituted each category was derived. The category reliability was calculated based on Scott’s formula for the matching rate of the classification by three qualitative researchers. The criterion for good reliability was set at 70%.
Results
Japanese men with sexual dysfunction associated with prostate cancer treatments experienced the following: a desire to maintain sexual function and conflict in decision-making concerning the initial treatment for prostate cancer; a loss of values related to sexual dysfunction; an uncertainty regarding the consequences of sexual dysfunction; a sense of calm with fewer adverse effects of sexual dysfunction at the early treatment stage; an effort to accept sexual dysfunction; and management of their changed body at the later treatment stages. The concordance rates for the categories were 70% and 78%. Additionally, there were glimpses of experiences common to all treatments and trends in treatment-specific experiences.
Conclusion
It is necessary to provide care based on the experience of Japanese men with sexual dysfunction after prostate cancer treatment.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Fitzmaurice C, Abate D, Abbasi N et al (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5:1749–1768. https://doi.org/10.1001/jamaoncol.2019.2996
2. Foundation for Promotion of Cancer Research (2020) Cancer Statistics in Japan-2019. https://www.mhlw.go.jp/content/10901000/000682244.pdf Accessed 18 Nov 2021
3. The Japanese Urological Association (2016) Clinical practice guideline for prostate cancer. Medical Review Co., Ltd, Osaka, 211–213. https://www.urol.or.jp/lib/files/other/guideline/23_prostatic_cancer_2016.pdf Accessed 18 Nov 2021
4. Hoffman KE, Penson DF, Zhao Z et al (2020) Patient-reported outcomes through 5 years for active surveillance, prostatectomy, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer. JAMA 323:149–163. https://doi.org/10.1001/jama.2019.20675
5. Ngoo KS, Honda M, Kimura Y et al (2019) Longitudinal study on the impact of urinary continence and sexual function on health-related quality of life among Japanese men after robot-assisted radical prostatectomy. Int J Med Robot 15:e2018. https://doi.org/10.1002/rcs.2018
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献